Medi World Middle East

06/12/2024

that saves – one tiny breath at a time!

Europlaz Technologies Ltd has developed a game-changing innovation for care, aiming to improve survival rates for and distressed babies.

Here’s why this matters:

Integrated design: Their patented CO2 sampling port, added to neonatal flow sensors, ensures precise monitoring while protecting delicate lungs.

Better outcomes: Combining lung-protective volume control with accurate CO2 readings reduces risks of long-term conditions like cerebral palsy and lung disease.

Proven success: Over 1 million sensors sold so far—without this addition. Now, they’re stepping up for even greater impact.

"Momentum is building, with two global manufacturers adopting our new flow sensors and trials starting soon at a major London hospital," said Frede Jensen, Product Development Manager at Europlaz.

"Our innovation provides accurate CO2 readings, equipping clinical teams with the tools they need to better support the tiniest lives."

Smart production for smarter care:

A cutting-edge robotic welder boosts production, ensuring every sensor is reliable and precise.

The goal? To supply 500,000 sensors annually and meet growing demand.

With trials kicking off at major UK hospitals, this innovation could set a new standard in neonatal ventilation. And yes, it’s about saving lives—but it also means reducing costs and potential litigation for healthcare systems.

So, what do you think? Should more manufacturers and hospitals adopt this life-saving technology?

06/12/2024

Dive into the latest issue of Mediworld Middle East!

From cutting-edge healthcare trends to in-depth interviews with industry leaders, we've got it all covered.

Explore now!

https://mediworldme.com/magazine/

Don't just read about innovation—experience it! Share your favorite articles or let us know what topics you'd love to see next.

05/12/2024

NEOTech Bridge: Revolutionizing Breastfeeding with Silicone

04/12/2024

Exciting news in the world of medical technology!

ZwickRoell, a leader in materials testing, has teamed up with Cormica® Medical Device & Pharmaceutical Testing, an FDA-compliant testing laboratory.

This new collaboration is set to provide early-stage development companies with the tools and expertise needed to accelerate product development and achieve proof of concept.

Here’s how this partnership benefits innovators:

Seamless Access: ZwickRoell customers now have direct access to Cormica MET’s FDA-compliant testing services and regulatory guidance.

Faster Market Entry: The collaboration streamlines the testing process, reducing the time it takes to get from concept to market.

Expert Support: Early-stage companies will receive the regulatory guidance needed to navigate complex medical device standards.

As Lee White, UK Sales & Marketing Manager at ZwickRoell, says: “This partnership will enable our customers to validate their innovations more effectively.”

"We look forward to working closely with ZwickRoell to support innovators in the medical technology space," said Angela B., Manager Medical Engineering Technologies Ltd said, "Together, we can offer a comprehensive solution that not only facilitates the testing process but also empowers our clients to navigate the complexities of regulatory compliance."

Are you part of a startup in the medical technology space?

29/11/2024

Meril is raising the bar in care with the launch of their next-generation Myval Octapro THV.

This new addition to their transcatheter heart valve portfolio continues the evolution of TAVR technology.

Key Highlights of the Myval Octapro THV:

Advanced Features: Reduced frame foreshortening for greater operator control and predictive deployment.

Size Flexibility: A range of valve diameters (conventional, intermediate, and extra-large) for better patient-specific fitting.

Strong Clinical Evidence: Backed by the LANDMARK RCT, showcasing its non-inferiority to contemporary valve series and demonstrating significant improvements in effective or***ce area (EOA).

Intermediate & XL Sizes: Unique to the TAVR landscape, offering more options for doctors and patients.

What’s the Impact? The Myval THV series has been instrumental in advancing transcatheter aortic valve replacement (TAVR) therapy, with clinically proven success across 31 centers worldwide.

Sanjeev Bhatt, Senior VP of Corporate Strategy at Meril, emphasizes that this new launch will continue to benefit patients and doctors globally.

Are you excited about the next phase in structural heart care? Share your thoughts or experiences with TAVR technology in the comments below!

27/11/2024

VUZE Medical Ltd. is breaking barriers in interventions with its revolutionary Tandem mode, showcased recently at the 2024 North American Spine Society meeting.

Here's why this matters:

Precision Meets Simplicity

The VUZE System doesn’t rely on markers, references, or cameras. It overlays 3D guidance onto 2D X-ray images using standard surgical tools, making complex navigation easier than ever.

Time & Radiation Savings

Tandem mode, though not yet clinically approved, allows two surgeons to work simultaneously on left-and-right-sided vertebral insertions—potentially cutting down both surgical time and radiation exposure.

World’s First Innovation

According to CEO David Tolkowsky, this dual-sided 3D guidance is a global first. It’s generating excitement among surgeons for its potential to optimize workflows and improve patient outcomes.

“Our newly-demonstrated Tandem mode is as far as we are aware a world first,” said David Tolkowsky, founder and CEO of VUZE Medical. “It is raising strong interest among surgeons due to the significant potential for a much-improved surgical workflow, a potential that will be further validated and quantified.”

Seamless Integration

The VUZE System works on standard PCs and integrates with pre-operative CT or in-OR 3D scans. No extra equipment means fewer hassles in the operating room.

Global Recognition

With 12 patents spanning the , , & , VUZE Medical is making waves not just in robotics and AR but also in traditional navigation systems.

“I believe the new Tandem mode has the potential for further reducing time and radiation during spinal interventions assisted by VUZE,” said Paul Slosar, MD, an orthopedic spine surgeon who practiced for 28 years in the San Francisco Bay area and consultant for VUZE. “Not only that, as in the FDA-cleared single-tool mode, no lateral X-ray images are needed at all, the same anterior-posterior images can now be used for simultaneously guiding left-and right-sided vertebral insertions performed by two surgeons working in parallel.”

The future of spinal surgery looks bright—and efficient!

What are your thoughts on how technology can further improve surgical workflows? Let us know in the comments!

27/11/2024

Did you know that timely care can save lives?

In , stroke incidents are a growing concern, but partnerships like the one between Boehringer Ingelheim and the Ministry of Health Saudi Arabia are paving the way for better outcomes.

Here's what they're doing to make a difference:

Expanding Telestroke Services

Boehringer Ingelheim’s Angels Initiative is enhancing stroke care accessibility through Seha Virtual Hospital.

This innovative network ensures 24/7 access to specialists, enabling quicker diagnoses and treatments.

Building Awareness and Education

Public awareness campaigns will focus on recognizing early warning signs of stroke.

Training programs for healthcare professionals will strengthen response times and care quality.

Leveraging Data for Better Care

A comprehensive Stroke Registry will provide valuable insights, driving evidence-based improvements in patient care.

This collaboration aligns with Saudi Arabia's to revolutionize healthcare.

Abdallah Hamed, General Manager at Boehringer Ingelheim, expressed excitement about expanding services through Seha Virtual Hospital, offering KSA patients 24/7 access to healthcare specialists. He emphasized their commitment to improving patient outcomes and supporting Saudi Arabia’s Vision 2030 through this partnership.

By reducing treatment delays and raising awareness, it’s ensuring a brighter future for stroke patients.

What’s your take? How can public-private partnerships further transform healthcare? Share your thoughts below!

25/11/2024

After over 20 incredible years with Medilink Midlands, 'Chris D**e', Head of Connectivity, is stepping into , leaving behind an inspiring legacy.

From his start as a Data Manager to his pivotal role today, Chris has been the backbone of Medilink’s evolution.

Here’s what makes Chris’s journey extraordinary:

Unwavering dedication: For two decades, Chris has passionately supported the medtech and life sciences community, helping countless businesses grow.

Master connector: His knowledge and connections have fostered partnerships that shaped Medilink and its members.

A lifetime of achievement: Honored at the Medilink Midlands Business Awards 2023, Chris received the Lifetime Achievement Award from Chair, Prof. Martin Levermore MBE DL.

A few words from those who’ve worked closely with him:

“Chris has been a driving force for growth, innovation, and opportunities in the sector.” – Prof Martin Levermore MBE DL, Committee Member at Association of Jamaican Nationals (Birmingham) UK.

“His passion and care have sparked fruitful partnerships across the region.” – Melanie Davidson.

“A font of all knowledge and a personal inspiration.” – Tammy Holmes.

Chris, your legacy will continue to inspire the Medilink Midlands community for years to come. Enjoy every moment of your well-deserved retirement!

What’s the best piece of advice you’ve received from a mentor or colleague?

Let’s celebrate those who make a difference—share in the comments below!

25/11/2024

Under the patronage of Her Highness Sheikha Fatima bint Mubarak, Cleveland Clinic Abu Dhabi successfully hosted its first-ever Annual Nursing Conference on November 20-21, focusing on Advancing Nursing Excellence in the UAE.

Here’s what made the conference special:

Global Expertise: Nurses gained valuable insights from renowned experts like Meredith Foxx and Nancy Albert from Cleveland Clinic Health System, USA.

Dynamic Discussions: Panel discussions on innovative practices, ethical considerations, leadership, and technology in healthcare.

Professional Development: Attendees earned American Nurses Credentialing Center (ANCC) contact hours to enhance their skills.

Key speakers included:

Prof. George Haber, CEO, Cleveland Clinic Abu Dhabi.

Elizabeth Govero DNP, MSN, Chief Nursing Officer, Cleveland Clinic Abu Dhabi.

Regional experts like John Tote and Zeina Kassem from Cleveland Clinic Abu Dhabi.

This conference marked a significant milestone in the UAE’s healthcare landscape, underscoring the essential role of nurses in improving patient care and driving innovation in healthcare.

What do you think about the future of nursing conferences in the UAE?

How can we continue to empower and elevate nursing professionals?

Let’s discuss below!

22/11/2024

Big news in !

Fluxergy is teaming up with National Institute of Allergy and Infectious Diseases (NIAID) to take molecular testing to the next level.

Their goal?

Faster, smarter & more accessible diagnostics for everyone.

Here’s what’s exciting:

Simple solutions for complex problems: Fluxergy is working on high-sensitivity tests for STIs and vaginosis, aiming to make testing faster and easier.

Powerful partnerships: With NIAID's support, they’re refining cutting-edge sample prep methods.

Real-world impact: These advancements could help fight antimicrobial resistance and improve healthcare access.

Building momentum: This follows their recent partnership with the Henry Jackson Foundation to bring sepsis testing to underserved areas.

"This collaboration will speed up our mission to deliver affordable, lab-quality tests that solve real healthcare challenges," says Tej Patel, CEO of Fluxergy.

How do you think innovations like this can reshape accessibility?

Let’s discuss!

21/11/2024

Tip of the Day!

Stay hydrated, but don’t just drink any liquid—water is your best friend!

It helps keep your skin glowing, your energy up, and your body functioning at its best.

Here’s a fun challenge: aim for 8 glasses today and see how you feel.

Your body will thank you!

How do you stay hydrated?

Drop your favorite water tricks in the comments!

19/11/2024

A New Era in Safer : Meets &

Did you know that X-rays—essential for and industrial monitoring—can pose risks due to ionizing radiation?

While single scans are generally safe, frequent exposure can have long-term effects, especially for technicians or sensitive equipment.

That’s why the latest in X-ray detection is a game-changer!

Now, researchers publishing in ACS Central Sciencehave taken a step toward safer X-rays by creating a highly sensitive and foldable detector that produces good quality images with smaller dosages of the rays.

Here’s what’s exciting about this new development:

Lower radiation doses, same high-quality imaging: Thanks to enhanced detector sensitivity, fewer X-rays are needed for clear images.

Revolutionary materials: Using specialized perovskite crystals, researchers have reduced background noise ("dark current") by half, improving detection by five times!

Versatile and foldable devices: Imagine X-ray machines that are portable, safer, and energy-efficient!

Precision matters: The new detector captured intricate details—like a metal needle inside a raspberry!

Why this matters: This technology isn’t just about better images—it’s about protecting patients, technicians, and the environment while improving diagnostic and monitoring outcomes.

"This advancement reduces detection limits and paves the way for safer and more energy-efficient medical imaging and industrial monitoring," says Omar F. Mohammed, MD, the corresponding author on the study.

What’s your take?

How can your industry or workplace benefit from safer and more sensitive technologies?

Share your thoughts below!



Materials provided by American Chemical Society.

18/11/2024

Boston Scientific Expands with Axonics, Inc. Acquisition!

Big moves are happening in the healthcare tech world!

Boston Scientific has successfully completed the acquisition of Axonics, Inc., a leader in innovative solutions for urinary and bowel dysfunction.

Here's what you need to know:

Enhanced Portfolio: Axonics' cutting-edge products in sacral neuromodulation are now part of Boston Scientific’s Urology business. This strengthens their position in a high-growth market.

Growth Opportunity: With an equity value of $3.7 billion USD, this acquisition opens doors to new treatments for patients dealing with incontinence.

Impact on Patients: The expanded portfolio allows Boston Scientific to offer tailored treatment options to meet patients' specific needs.

Why it Matters: This acquisition is a prime example of how strategic mergers can drive innovation and better outcomes for patients

“Over the last decade, it has been impressive to see the meaningful innovations Axonics has delivered for patients with overactive bladder and incontinence,” said Meghan Scanlon, Senior Vice President and President, Urology, Boston Scientific.

By tapping into Axonics' advancements, Boston Scientific is preparing to meet the growing demand for specialized treatments.

What are your thoughts on the future of the urology and medical technology sectors?

Let’s discuss in the comments below!

17/11/2024

Breaking news!

Clinisys has reached a major milestone with the completion of phase three of the CoreLIMS program, deploying the WinPath Laboratory Information Management System (LIMS) across all health trusts and the blood transfusion service in Northern .

This isn't just another IT upgrade—it's a leap towards integrated, efficient, and patient-centric healthcare.

Here’s why this matters:

Streamlined Processes: A unified LIMS standardizes workflows, ensuring consistency and precision across pathology services.

Data-Driven Care: The integration supports new electronic patient records and imaging systems, paving the way for a single digital health record for every citizen.

Enhanced Safety: By 2026, blood tracking from 'vein to vein' will become a reality, improving efficiency and patient safety.

The Big Picture: services in Northern Ireland perform over 40 million tests annually and employ 1,100+ staff.

This program isn't just modernizing IT—it’s laying the groundwork for innovations like digital pathology and .

Health Minister Mike Nesbitt said: “A world class digital healthcare service is at the heart of our future healthcare needs. This will enable us to better manage demand, standardise reporting across the health service, and ensure a better service for patients.”

Karin Jackson, chief executive of NIBT, said: “Years of preparation, testing, testing, and hard work have brought the CoreLIMS project to this point. Yet again, this has been tremendous work by an amazing team. Well done to all trust staff, the BSO and Clinisys on another great milestone achieved on this CoreLIMS expedition.”

Melissa Cochrane, head of programmes delivery at the BSO IT Services division, said one benefit of having the same LIMS in use at the NIBTS and trusts is that it will be able to implement ‘vein to vein’ blood tracking from early 2026: “We have a blood production and tracking project that we are very proud of,” she said. “We will know where all our blood is at any given time, which is making the system much more efficient, and safer.”

Robin Bell, senior project manager at Clinisys, said the phase three go-lives had gone smoothly, and that was down to the efforts that had be

Kudos to everyone involved!

Your dedication has ensured a smooth rollout and brought Northern Ireland closer to a world-class healthcare system.

Your turn!

What do you think are the biggest challenges in implementing large-scale digital transformation projects like this?

Share your insights or experiences in the comments!

15/11/2024

Zimmer Biomet has just teamed up with none other than Arnold Schwarzenegger as their first-ever Chief Movement Officer!

A true icon in fitness, Arnold’s mission aligns perfectly with Zimmer Biomet’s goal: promoting healthier, active lives through movement.

Here’s what this partnership means:

Inspiring Daily Movement: Arnold’s lifelong commitment to fitness will encourage everyone to embrace mobility and joint health as key parts of their routine.

Elevating Joint Health Awareness: With Arnold’s influence, Zimmer Biomet aims to spotlight how crucial joint health is to quality of life.

Living “If You Rest, You Rust”: Arnold’s motto says it all. This partnership will help people realize that movement isn’t just about fitness—it’s about enhancing joy and longevity!

Ivan Tornos, President and Chief Executive Officer of Zimmer Biomet said: "Arnold's bold approach to personal health, innovation and evolution echoes Zimmer Biomet's vision to be the boldest company in MedTech by solving the most meaningful problems in healthcare today. People are seeking to lead healthier, more active lifestyles as they age, and the demand for people to keep moving pain-free is increasing.

Arnold Schwarzenegger added: "I am energised by Zimmer Biomet's Mission because it aligns with my own 50-year fitness crusade. I want every single person in the world to discover the joy of fitness and movement that has made my life better every step of the way. Through this partnership with Zimmer Biomet, I can continue to encourage others to make positive changes each and every day that support them living their best and most active lives possible.

What’s your go-to movement for staying active?

Whether it’s a daily walk or hitting the gym, share your routines below!

Arnold Schwarzenegger

14/11/2024

At the Longevity World Forum, M42 Health's Managing Director and Group CEO, Hasan Jasem Al Nowais, called on global leaders to shift from sickness to prevention in healthcare.

With healthcare costs projected to reach US$10 trillion by 2026, the current model is unsustainable.

Al Nowais showcased how M42 is integrating and to disrupt traditional models.

Their innovations include the Med42 language model, AI-powered chest X-rays for early tuberculosis detection, and AI in endoscopic colon screening.

"Early detection and diagnosis, and then prevention, are key," he said.

testing and genomics were highlighted as transformative in preventative medicine.

M42's advancements enable early interventions tailored to individual .

A case study illustrated the impact of genetic testing in identifying cancer risks early, allowing for proactive health management.

Al Nowais emphasized the need for global collaboration to democratize healthcare.

"The future of the world is in healthcare, and the future of healthcare is prevention," he urged.

He called for sharing knowledge and resources to make advanced care accessible to all.

The Longevity Forum also hosted discussions on technologies and research supporting preventative medicine.

M42 continues to lead with its data-centric and human-centric approach, including the Emirati Genome Program, collecting almost 600,000 genome samples.

What are your thoughts on the shift towards ?

How can AI and genomics drive this change?

Let's discuss!

14/11/2024

Exciting news from Billerud!

The launch of MediKraft SealBase marks a significant step forward in the medical industry.

Designed to meet the evolving needs of medical applications, this innovative surface-treated medical paper was unveiled in mid-November 2024 at COMPAMED in Düsseldorf.

MediKraft SealBase, made from pure virgin fiber, is produced at Billerud's Skärblacka mill in Sweden.

The 38 gsm grade product is tailored for medical synthetic cold seal coatings and offers a versatile solution for non-sterile medical applications like plasters.

This extends Billerud's product line, demonstrating their commitment to providing cutting-edge solutions.

An integrated pulp production process ensures complete control over manufacturing, supported by comprehensive quality control systems.

MediKraft SealBase not only promises high performance but also boasts advanced sustainability credentials, reinforcing Billerud's reputation for environmentally responsible products.

Robert James Torstensson, Vice President, Business Area Paper at Billerud, emphasized that this launch allows Billerud to cater to a wider range of medical applications and customers seeking alternatives to traditional latex-based products. It's a strategic move that underscores their dedication to innovation and customer satisfaction.

“MediKraft SealBase demonstrates our commitment to the medical segment and providing innovative solutions to our customers. This is a strategic step in broadening Billerud's product portfolio in medical paper, allowing us to cater to a wider range of medical applications and customers seeking alternatives to traditional latex-based cold seal products.

What are your thoughts on the future of medical packaging?

Do you think innovations like MediKraft SealBase will set new industry standards?

Let's discuss!

13/11/2024

Stay ahead with Mediworld Middle East!

Don’t miss out on the latest , news & exclusive interviews across and .

Our keeps you informed with top trends, cutting-edge innovations and expert opinions every month!

Why Subscribe?

🔹 Get insider access to expert articles.

🔹 Stay updated on global healthcare advancements.

🔹 Be part of a community shaping the future of wellness.

Ready to join?

https://mediworldme.com/

Subscribe now at mediworldme.com to never miss an issue!

Gilead Sciences: A New Era of Local Healthcare Solutions In this exclusive interview, Eid Mansour talks about Gilead Sciences’ strategies for enhancing patient care and access to innovative treatments in Saudi